| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.29▲ | 4.29▲ | 4.27▲ | 4.28▲ | 5.27▼ |
| MA10 | 4.32▼ | 4.27▲ | 4.27▲ | 4.88▼ | 5.31▼ |
| MA20 | 4.27▲ | 4.25▲ | 4.21▲ | 5.51▼ | 5.98▼ |
| MA50 | 4.26▲ | 4.23▲ | 4.63▼ | 5.45▼ | 7.80▼ |
| MA100 | 4.19▲ | 4.83▼ | 5.44▼ | 6.21▼ | 11.27▼ |
| MA200 | 4.67▼ | 5.44▼ | 5.46▼ | 7.44▼ | 16.97▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | 0.015▲ | 0.053▲ | -0.199▼ | -0.039▼ |
| RSI | 53.001▲ | 54.051▲ | 47.562▼ | 33.132▼ | 36.911▼ |
| STOCH | 44.180 | 46.811 | 51.893 | 7.747▼ | 34.720 |
| WILL %R | -47.368 | -39.130 | -23.077▲ | -88.502▼ | -89.355▼ |
| CCI | -7.609 | 30.382 | 53.687 | -96.717 | -191.678▼ |
| CDL | $ALGS Doji Candlestick Pattern Detected | Set Alert |
|
Monday, July 13, 2026 05:00 AM
SOUTH SAN FRANCISCO, Calif., July 13, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, "Aligos"), a clinical stage biopharmaceutical company focused on developing novel therapeutics ...
|
|
Sunday, July 05, 2026 04:59 PM
Detailed price information for Aligos Therapeutics Inc (ALGS-Q) from The Globe and Mail including charting and trades.
|
|
Monday, March 30, 2026 05:01 PM
Detailed price information for Aligos Therapeutics Inc (ALGS-Q) from The Globe and Mail including charting and trades.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 29/07/26 | 4.305 | 4.40 | 4.18 | 4.31 | 44,757 |
| 28/07/26 | 4.22 | 4.37 | 3.98 | 4.25 | 87,135 |
| 27/07/26 | 4.09 | 4.27 | 3.98 | 4.08 | 213,037 |
| 24/07/26 | 4.80 | 4.8052 | 4.0049 | 4.08 | 201,814 |
| 23/07/26 | 5.05 | 5.20 | 4.6006 | 4.69 | 147,423 |
| 22/07/26 | 5.49 | 5.50 | 5.08 | 5.15 | 58,028 |
| 21/07/26 | 5.335 | 5.80 | 5.21 | 5.44 | 58,806 |
| 20/07/26 | 5.72 | 5.72 | 5.195 | 5.28 | 85,109 |
| 17/07/26 | 5.70 | 5.85 | 5.60 | 5.74 | 46,970 |
| 16/07/26 | 5.77 | 6.12 | 5.64 | 5.75 | 54,508 |
|
|
||||
|
|
||||
|
|